SPC Financial Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$451K Buy
592
+4
+0.7% +$2.98K 0.04% 179
2025
Q2
$458K Sell
588
-6
-1% -$4.66K 0.04% 172
2025
Q1
$491K Sell
594
-4
-0.7% -$3.33K 0.04% 166
2024
Q4
$462K Buy
598
+66
+12% +$54.6K 0.04% 171
2024
Q3
$471K Buy
532
+26
+5% +$23.4K 0.04% 181
2024
Q2
$458K Sell
506
-7
-1% -$5.6K 0.04% 168
2024
Q1
$399K Sell
513
-8
-2% -$5.69K 0.04% 177
2023
Q4
$304K Buy
521
+36
+7% +$21K 0.03% 188
2023
Q3
$260K Buy
485
+9
+2% +$4.64K 0.03% 190
2023
Q2
$223K Buy
+476
New +$200K 0.02% 203
2013
Q4
Sell
-4,850
Closed -$244K 104
2013
Q3
$244K Hold
4,850
0.09% 92
2013
Q2
$238K Buy
+4,850
New +$264K 0.09% 89

Other funds holding LLY

SPC Financial Inc's LLY Position: Q3 2025 in Review

SPC Financial Inc increased its Eli Lilly (LLY) stake by 0.68% in Q3 2025, buying an estimated $2.98K and bringing the position to 592 shares worth $451K. The position accounts for 0.04% of the portfolio, ranked #179.

SPC Financial Inc first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $491K in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • SPC Financial Inc held 592 shares of Eli Lilly worth $451K as of Q3 2025.
  • SPC Financial Inc bought 4 Eli Lilly shares in Q3 2025, an estimated $2.98K.
  • Eli Lilly made up 0.04% of SPC Financial Inc's portfolio in Q3 2025, its #179 holding.
  • SPC Financial Inc first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • SPC Financial Inc's Eli Lilly position peaked at $491K in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on SPC Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.